2011
DOI: 10.1016/s1642-431x(12)60048-5
|View full text |Cite
|
Sign up to set email alerts
|

Elevated expression of KiSS-1 in placenta of preeclampsia and its effect on trophoblast

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
27
1
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(34 citation statements)
references
References 22 publications
4
27
1
2
Order By: Relevance
“…Despite kisspeptin-10 being the most potent physiological inhibitor of trophoblast invasion in the placenta [16], most preeclampsia studies have focused on the expression of different forms of kisspeptins ( Table 3). The finding of elevated kisspeptin expression in preeclamptic placentae concurs with those from previous studies [22,24]. In addition trophoblasts isolated from preeclamptic placentae exhibit increased Kiss-1 mRNA and metastin (kisspeptin-54) expression and this expression correlates positively with the severity of disease [20].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Despite kisspeptin-10 being the most potent physiological inhibitor of trophoblast invasion in the placenta [16], most preeclampsia studies have focused on the expression of different forms of kisspeptins ( Table 3). The finding of elevated kisspeptin expression in preeclamptic placentae concurs with those from previous studies [22,24]. In addition trophoblasts isolated from preeclamptic placentae exhibit increased Kiss-1 mRNA and metastin (kisspeptin-54) expression and this expression correlates positively with the severity of disease [20].…”
Section: Discussionsupporting
confidence: 90%
“…In contrast the placental expression of both Kiss-1 and GPR-54 transcripts are highest in the first trimester (when control of invading trophoblasts is most crucial) and lowest at term [16,19]. Several studies have reported elevated Kiss-1 mRNA and protein expression in trophoblasts [20] and placentae of pregnancies complicated by preeclampsia [21][22][23][24]. Cartwright and Williams (2012) reported increased kisspeptin receptor expression in preeclamptic placentae [21], while Qiao et al (2012) found no difference in placental Kiss-1R mRNA and protein expression between healthy and preeclamptic pregnancies [22].…”
Section: Introductionmentioning
confidence: 99%
“…In this study, the development of preeclampsia was found to be associated with deregulation in the levels of H3K9/27me3, showing increased levels of H3K9me3 and both H3K9/27me3 associated with low expression of MMP2 and MMP9 respectively. These results support the documented deficient expression of MMP2 and MMP9, in preeclampsia (Lockwood et al 2008, Zhang et al 2011. MMPs also play important role in controlling the bioactivity of growth factors, angiogenic factors, cytokines (Staun-Ram & Shalev 2005), and release of VEGF (Monaco et al 2006), thus their deficient expression in preeclampsia might also be hampering the VEGF release, as supported by lower levels of VEGF reported in preeclampsia (Levine et al 2004).…”
Section: Discussionsupporting
confidence: 81%
“…Similar to what is reported in other cases of shallow trophoblast invasion (e.g. pre-eclampsia), (Sood et al 2006;Lian et al 2010;Mayor-Lynn et al 2011;Zhang et al 2011), we expected that MMP2 and MMP9 would be expressed in isolated canine trophoblasts and canine placental tissues. Using RT-PCR, Lei et al (2007) reported an upregulation in MMP9 expression that was associated with differentiation of mouse trophoblast stem cells expected to occur at the end of pregnancy.…”
Section: Discussionsupporting
confidence: 79%